Osteoporosis is a significant public health concern that affects millions of individuals, particularly women over the age of 50. At the same time, advances in breast cancer treatment have significantly improved survival rates, allowing more women to live longer after diagnosis. However, several common breast cancer treatments can accelerate bone loss and increase the risk of osteoporosis and fractures.
Learning Objectives:
- Describe the pathophysiology of osteoporosis and factors that influence bone health
- Identify major risk factors associated with the development of osteoporosis
- Explain how breast cancer and its treatments can contribute to decreased bone density
- Discuss the role of bone densitometry in the diagnosis and monitoring of osteoporosis
- Recognize strategies for prevention and management of osteoporosis in patients undergoing breast cancer treatment
Cassling strengthens community healthcare through customer-centric imaging and therapeutic technology, services and solutions. From critical access hospitals and diagnostic imaging centers to large health systems and IDNs, Cassling is committed to helping healthcare organizations improve access and outcomes, create efficiencies and lower costs.
Comments